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Immunological memory is a hallmark of adaptive immunity, and
understanding T cell memory will be central to the development of
effective cell-mediated vaccines. The characteristics and functions
of CD4 memory cells have not been well defined. Here we dem-
onstrate that the increased size of the secondary response is solely
a consequence of the increased antigen-specific precursor fre-
quency within the memory pool. Memory cells proliferated less
than primary responding cells, even within the same host. By
analyzing the entry of primary and memory cells into the cell cycle,
we found that the two populations proliferated similarly until day
5; after this time, fewer of the reactivated memory cells prolifer-
ated. At this time, fewer of the reactivated memory cells made IL-2
than primary responding cells, but more made IFN. Both these
factors affected the low proliferation of the memory cells, because
either exogenous IL-2 or inhibition of IFN increased the prolifer-
ation of the memory cells.
interferon gamma  interleukin 2  proliferation  LCMV  recall
Immunological memory is a defining characteristic of theadaptive immune response and can be manifested by antigen-
specific B cells and CD4 and CD8 T cells (1). Work of the last
10 years has tremendously advanced our knowledge of CD8 T
cell memory (2). It is now generally accepted that, as a popu-
lation, memory CD8 T cells are maintained at fairly constant
numbers (3) and provide protection more effectively than naı¨ve
cells (4). In contrast, the maintenance and functional capabilities
of memory CD4 T cells are still controversial (5–9).
Some of the confusion about CD4 memory T cells may lie in
the use of TCR transgenic (Tg) cells primed either in vitro (8) or
in vivo (10). Although these cells have provided a wealth of
knowledge about the early stages of CD4 T cell responses (11),
their usefulness in memory cell studies is less clear, as they are
often used at unnaturally high frequencies, which can lead to
anomalous results (12, 13).
Although cytokines affect both the generation and survival of
CD4 memory T cells (14), their production by antigen-specific
memory cells after reactivation is not well defined. The classi-
fication of memory cells into T effector memory (TEM) and T
central memory (TCM) (15) suggests that, whereas some mem-
ory cells may make an enhanced effector response, a second
subset still have the capacity to produce IL-2 and proliferate well.
Studies using TCR Tg cells have indicated that this may be the
case (16, 17) but, since these experiments were done by using
large numbers of transferred TCR Tg cells, such results may not
reflect events in unmanipulated animals.
To avoid such issues, we have used MHC class II/peptide
tetramers to examine antigen specific endogenous CD4 memory
cells in intact hosts, tracking them through initial activation and
contraction and during subsequent responses in vivo. Although
CD4memory T cells proliferated in response to antigen, they did
not divide as efficiently as primary responding cells at later time
points. This reduced proliferation was accompanied by a de-
crease in the percentage of cells making IL-2 and an increase in
IFN production. Addition of IL-2 or blockage of IFN in vivo
increased the proliferation of the memory cells to that of the
primary responding cells. This work demonstrates that reacti-
vated CD4 memory cells, via the cytokines they do and do not
produce, limit their own proliferation upon antigen stimulation
in vivo.
Results
Secondary Responses Are Larger and Peak Earlier than Primary
Responses. To study endogenous memory CD4 T cell responses,
we immunized C57BL/6 (B6) mice with the IAb-binding peptide,
3K, and tracked the response using IAb/3K class II tetramers
(18). The number of tetramer (tet) cells was determined as
described in Materials and Methods and background staining set
by the number of tetCD44hi cells in naı¨ve mice.
To examine the kinetics with which memory CD4 T cells
responded to IAb/3K, B6 mice were primed with 3KLPS i.v.,
rested for 4–20 weeks, then reimmunized. At this point, age-
matched naı¨ve mice were primed to allow us to measure the
primary response. Supporting information (SI) Fig. S1 shows
sample FACS plots of tet staining and the phenotype of the
primary and secondary memory cells. The primary response
peaked on day (d)9, whereas the secondary response peaked
earlier, on d5, and the number of tet cells was greater in the
secondary than the primary response at their respective peaks
(Fig. 1A). This increased size was not due to activation of both
naı¨ve and memory cells, because the secondary response in mice
that had been thymectomized (Tx) before priming was the same
as in sham-Tx mice (Fig. S2).
We also examined the migration of primary and secondary
responding cells. At d5, we found there were more tet cells in
all organs examined in the secondary response (Table S1).
However, this reflects the total increased number of tet cells
in the secondary response rather than an alteration in migration
patterns. Moreover, we did not find a significant migration of the
reactivated memory cells out of the spleen after day 5; in
contrast, the number of cells present in the liver of secondary
responding mice decreased between d5–7 (Fig. 1B).
Memory CD4 Cells Expand Less Efficiently than Naı¨ve Cells to Ag
Stimulation. The larger size of the secondary response could be
due to three nonmutually exclusive factors: the increased num-
ber of Ag specific cells; enhanced proliferation by the memory
cells; and/or reduced death of the memory cells. To investigate
this, we first needed to know the number of IAb/3K-specific cells
in the naı¨ve and memory pool.
To count the number of naı¨ve IAb/3K-specific cells, we
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transferred different numbers of TCR Tg cells that respond to
IAb/3K into naı¨ve congenic hosts. After immunization with
3KLPS, both the transferred cells and the host response could
be measured with tetramer and the populations distinguished by
Thy expression. By transferring different numbers of cells and
analyzing the percentage of total tet cells that were host-
derived, we were able to determine when the starting population
of Tg cells and host IAb/3K specific cells were equal, i.e., when
the host response was 50% of the total response. This occurred
after the transfer of 500 Tg cells (Fig. 2A). We and others (19,
20) have found that 10% of cells survive after transfer. After
the transfer of 500 cells, 50 would be expected to respond to
a subsequent immunization, suggesting there are 50 naive
IAb/3K specific cells in a mouse.
There are caveats to this indirect method of counting naı¨ve Ag
specific cells, so we directly counted the number of naı¨ve
IAb/3K-specific cells in mice by staining total spleen and lymph
node (LN) cells from naı¨ve B6 mice with tetramer and analyzing
all these cells by FACS (see Materials and Methods for details).
By gating on live naı¨ve CD4 T cells (Fig. 2B), we identified 70
IAb/3K-specific cells per mouse (Fig. 2C). Because we did not
collect every LN, and there may have been some naı¨ve IAb/3K-
specific cells in the blood, this may be an underestimate, but this
number is similar to that found in the Tg cell experiment and to
that described for T cells with other specificities (19–21). To set
a level of background staining, we examined tetramer staining of
naı¨ve CD4 T cells from mice that had been primed with an
optimal dose of 3KLPS 7–9 days earlier. In these mice, we
believe all of the Ag-specific cells capable of responding should
up-regulate surface CD44 and should not be present in the naı¨ve
cell gate. We counted 20 cells per immunized mouse in this gate,
suggesting that 70 IAb/3K-specific cells per mouse may be a slight
overestimate.
Using this number of naı¨ve IAb/3K-specific T cells (70) and the
number of tet cells at the peak of the response (6–30  103),
we calculated that the fold expansion of the primary responding
cells was100 (Fig. 2D). The fold expansion of the memory cells
was calculated to be 20-fold by comparing the number of
memory cells present before the second immunization and the
number of cells at the peak. The time between the two immu-
nizations did not affect this result (Fig. 2D), indicating that,
because memory cells declined over time, the number of cells in
the memory pool did not determine their fold expansion.
Reduced Fold Expansion of Memory Cells Is Intrinsic to the Cells.
Immunization results in an increase in the number of IAb/3K-
specific T cells compared with that in naı¨ve mice. Therefore,
upon reexposure to the same dose of 3KLPS, this increased
frequency could result in greater competition for resources such
as Ag, antigen-presenting cells (APC), or cytokines.
To test this, we used a system that allowed us to track a primary
and memory response in the same host by transferring surface-
marked IAb/3K memory cells from immunized to naı¨ve mice. To
obtain enough of these cells, we used cells from mice that had
been immunized twice. Such cells had the same markers and
proliferative capacity as secondarily responding cells (Figs. S1
and S3 and data not shown).
Naı¨ve B6.PL mice were given Thy1.2memory cells, or control
mice received the same number of cells from naı¨ve animals.
Recipients were primed with 3KLPS, and the numbers of trans-
ferred and host IAb/3K-specific cells measured. The memory cells
peaked on d5, whereas the host cells peaked, as usual, on d9
whether or not their hosts contained transferred memory cells
(Fig. 3A). These data indicate that the lower fold expansion of
the memory cells was not due to competition but rather to a cell
intrinsic factor. Although it is possible that the memory cells
competed with each other for a factor not used by primary
responding T cells, we think this is unlikely. If they did, the response
would be increased when the cells were present at very low
frequencies. In contrast, we found that, regardless of the number of
memory cells present (compare Figs. 1 and 3), the kinetics and fold
expansion of the memory response were the same.
To test whether the frequency of Ag-specific cells affected
their fold expansion, we transferred different numbers of cells
from memory B6 mice into naı¨ve B6.PL mice. We found that the
number of tet donor cells correlated with the number of cells
transferred (Fig. 3B). The size of the primary responses in these
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Fig. 1. The CD4 T cell secondary response peaks earlier and is numerically
larger than the primary response. (A) B6 that had been primed with 3KLPS
4–20 weeks earlier (squares) and naı¨ve mice (triangles) were immunized with
3KLPS i.v. At the indicated time, splenocytes were isolated and the number
of IAb/3K tet cells analyzed. As a control, splenocytes from naı¨ve B6 mice
were also stained to indicate a level of background staining (gray line). Data
points represent the mean/SEM from 4 time course experiments with 3–4
mice per group. (B) Spleens (squares) and livers (triangles) were taken at d5
and d7 of a primary (black) or secondary (gray) response to 3KLPS and the
number of tet cells examined. The points indicate the mean SEM of four
mice per group.
Fig. 2. Memory cells undergo a lower fold-expansion than naı¨ve cells. (A)
Two hundred, 500, or 2 104 IAb/3K-specific TCR Tg cells were transferred into
naı¨ve B6.PL mice and the recipients primed the next day with 3KLPS i.v. Six
days later, splenocytes were isolated and the number of TCR Tg and host
Ag-specific CD4 T cells analyzed. The percentages of the total tet that were
host-derived were calculated. Each point represents one mouse, and the line
shows the mean of the groups. Data from one experiment after the transfer
of 200 or 20,000 Tg cells, four (indicated by different symbols) after the
transfer or 500 cells. (B) Total spleen and LN cells from naı¨ve or recently primed
B6 mice were stained with tetramer. Cells are gated as detailed in Materials
andMethodson naı¨ve CD4 cells. Plots are overlays of all six samples collected
from one naı¨ve and one primed mouse. The number indicates the mean
percentage of cells within the gate. (C) As in B, but the mean number of cells
within the naı¨ve-tetgate for each mouse is shown by each point and the line
shows the mean of the group. Data are from two experiments with three to
four mice per group. (D) B6 mice were either primed (white bar) or primed
then immunized a second time after the indicated length of time. The fold
expansion of the primary responding cells was calculated by comparing the
difference between the number of tet cells at d9 and the estimated number
of naı¨ve Ag specific cells (70). The fold expansion of the memory cells was
calculated by comparing the number of tet present on d5 after the second
immunization to the number of memory cells in a cohort of mice that were not
immunized again.
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hosts was unaffected by the memory cells, suggesting neither the
memory cells nor any regulatory cell or factor that may have
been transferred, nor any any limiting factor created by the
memory cells in the host, affected the size of the primary T cell
response.
Memory Cells Proliferate Less at Later Stages of the Response. The
low expansion could have been due to reduced proliferation or an
increase in cell death. To test this, the rates of proliferation of
memory and naı¨ve cells were examined. The memory transfer
system was used for these experiments, as it allowed us to examine
the responses in the same host. Memory cells from B6 or B6.PL
mice were transferred into either B6.PL or B6 animals, respectively.
The animals were immunized and, at various times thereafter,
injected with BrdU i.p. to label cells in cycle. Fifteen hours later, T
cells were analyzed by flow cytometry. For both primary responding
host and memory-transferred populations, the percentage of cells
in cycle dropped from 50% to 60% on d3 to 20–30% on d5 (Fig.
3C). These data suggest there was no distinction in the capacity of
primary or memory cells to proliferate during the first 5 days.
The primary response peaked on d9, so these cells must
continue to increase between d5 and d9. In contrast, after d5, the
number of secondary responding cells started to drop. Because
after i.p. injection the half-life of BrdU is very short (22), and
the percentage of cells in cycle dropped dramatically by d5, we
administered BrdU continuously in drinking water over a 2-day
period. Between d5 and d7, 40–70% of the primary responding
cells were BrdU, but only 10–25% of the memory cells had
divided (Fig. 3D). Therefore, the majority of the memory cells
stopped proliferating earlier than the primary responding cells.
We confirmed this was not an artifact of the transfer system, nor
a difference between secondary and tertiary responding cells by
giving BrdU drinking water to separate primary and secondarily
responding mice and found the same result (Fig. S4).
Although Fewer Memory Cells Make IL-2, More Make IFN. The
memory T cells might curtail their response because they are less
able to maintain production of growth factors, such as IL-2. The
number of IL-2 cells was the same in the primary and
secondary response (Fig. S5). However, because there were
more tet cells in the secondary response, the relative percent-
age of Ag-specific cells making IL-2 was reduced (Fig. 4A).
This drop in the frequency of cells making IL-2 may have been
caused by a switch to effector cytokine production. Because we
used LPS, which induces a Th1 response, we measured IFN
production. Ex vivo Ag stimulation did not induce IFN above
background in the primary response (Fig. S5), but a small
number of the reactivated Ag-specific memory cells were IFN
(Fig. 4A).
Frequency of Cells Making IL-2 and IFN Affect the Proliferation of
Reactivated Memory Cells. To test whether these cytokine changes
caused the reduced proliferation, the effects of additional IL-2
or blockage of IFN were measured. Naı¨ve B6 mice that had
been given IAb/3K-specific memory cells from B6.PL mice were
Fig. 3. The frequency of memory cells does not affect their expansion, which
is less than primary responding cells only at later stages of the response. (A)
2–3 107 total cells from B6 mice immunized twice with 3KLPS (B6 memory
mice) were transferred i.v. into naı¨ve B6.PL mice and the recipients immunized
the next day with 3KLPS i.v. The mean number of either memory or primary
cells in the same mouse is shown / SEM. As a control, the primary host
response was examined in separate mice that received naı¨ve B6 cells (closed
triangles). Representative of three experiments with three to four mice per
group. (B) The transfer of cells from B6 memory mice was carried out as in A
at three different frequencies: : 7  106 total cells, 550 tet, : 20  106
total, 1,500 tet, : 50  106 total, 4,000 tet. The recipients were
immunized the next day with 3KLPS i.v. On d5, the number of tet primary
(open squares) and memory (closed squares) cells in the spleen was examined.
Each point represents a mouse and the line shows the mean. Representative
of two experiments. (C) As inA, but recipients were given 1 mg of BrdU i.p. 15 h
before death. The percentages of BrdU-tet primary (open squares, black
line) or memory cells (closed squares, gray line) were calculated. Each point
represents the mean/ SEM on each day. Results are representative of three
experiments with three to four mice per group.(D) As in C, but the recipient
mice received drinking water containing BrdU continuously from d5 to d7. The
mean percentages / SEM of primary (open bars) and memory cells (gray
bars) that were BrdU on d7 are shown. Representative of three experiments
with four mice per group.
Fig. 4. Proliferation of the memory cells is affected by their cytokine
production. (A) B6 mice primed with 3KLPS i.v. 4 weeks earlier (secondary)
or naı¨ve age-matched mice (primary) were immunized with 3KLPS i.v. and
splenocytes isolated 5 days later. Cells were either stained with tetramer to
enumerate Ag-specific cells or incubated with/without peptide in the pres-
ence of Golgi plug for 6 h and the number of IL-2 or IFN cells calculated. The
percentage of tetramer cells making cytokine was calculated as described in
Materials and Methods. Results are representative of four experiments with
three to four mice per group. Error bars are SEM. (B) Naı¨ve recipients of IAb/3K
memory cells were immunized with 3KLPS (d0) then treated with PBS (closed
symbols) or 1.5 g of IL-2 (open symbols) i.p. on d3–6 and given BrdUwater
from d5 to d7. On d7, splenocytes were stained with tetramer and anti-BrdU
and the percentage of doubleprimary (triangles) and memory cells (squares)
measured. The symbols indicate each mouse, and the line shows the mean.
Representative of two experiments with four mice per group. (C) As in B, but
memory cell recipients were given 1 mg of control rat or anti-IFN on d3–4 i.p.
(D) Irradiated CD45.1 mice reconstituted with 50% WT CD45.1 and 50% IFNR
KO bone marrow were immunized i.v. with 3KLPS after 8 weeks. Thirty days
later, the numbers of tetWT or KO CD4 cells were examined in the spleens
of memory mice (diamond) or in memory (squares) or naı¨ve (triangles) mice
immunized 7d previously with 3KLPS. Tetramer staining in naı¨ve chimeras is
shown as a staining control (circles). Cells were gated on live CD4 cells that
were dump-negative and either CD45.1 (WT, closed symbols) or CD45.2
(KO, open symbols). Each point represents a chimera, and the line shows the
mean of the group. Representative of two experiments with three to four mice
per group.
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immunized on d0 and treated with either IL-2 or anti-IFN or,
as controls, PBS or rat IgG, between d3 and d6. All mice were
given BrdU drinking water on d5–7.
Treatment with either IL-2 or anti-IFN restored the per-
centage of Ag-specific memory cells that were BrdU to the
same level as that of the primary responding cells (Fig. 4 B and
C). Notably, the primary responding cells were unaffected by
either treatment. As there was little change in the number of
either population between d5 and d7, we did not expect to see
a large difference in the number of tet cells in treated mice. We
did, however, find a significant increase in the number of
memory tet cells after treatment with anti-IFN on one
occasion and, when considered as a whole, there is a trend
toward an increase in the number of memory cells after either
treatment (data not shown).
IFN Does Not Directly Inhibit Memory Cell Proliferation. To test
whether IFN acted directly on the memory T cells, we made
bone marrow chimeras reconstituted with 50% WT and 50%
IFN receptor (IFNR) KO bone marrow. These chimeras were
immunized and 30 days later the secondary response of the WT
and KO CD4 T cells examined. We also measured the number
of primary and memory tet cells. There were equal numbers of
WT and KO tet cells at all stages of the response (Fig. 4D),
suggesting that IFN does not directly affect T cell proliferation
but rather acts through another cell type.
Memory Cells Either Generated by or Reactivated with Lymphocytic
Choriomeningitis Virus (LCMV) Also Proliferate Poorly. It was possible
that the low fold expansion of the memory cells was a result of
poor differentiation after immunization with 3KLPS, exem-
plified by the low IFN response. Therefore, we examined the
reactivation of CD4 memory cells specific for GP61 (23) gen-
erated after infection with LCMV, an agent that induces excel-
lent CD4 T cell IFN production [data not shown and (7)].
B6 mice were infected with LCMV or immunized with GP61
peptideLPS. After 40 days, we counted the numbers of CD4
IAb/GP61tet cells either in these animals or in thesemice or naı¨ve
mice that had been immunized 5 days earlier with GP61LPS.
Reinfection with LCMV was not used to avoid complications
because of preexisting antibody or LCMV-specific CD8T cells. The
memory cells in both the LCMV- andGP61-primedmice expanded
poorly in response to GP61LPS with LCMV memory cells
expanding 5-fold, whereas GP61LPS memory cells expanded
10-fold (Fig. 5A). Whitmire et al. (19) have shown there are 100
GP61-specific naı¨ve cells in B6 mice (19), and we found a similar
number (160) after directly labeling total spleen and lymph node
cells with IAb/GP61tet (Fig. S6). Using this number, the primary
responding cells expanded 300-fold in response to GP61LPS
from d0 to d5.
We also examined the IL-2 response by primary and reacti-
vated GP61-specific cells and found that, as for 3KLPS mem-
ory cells, the percentage of both LCMV and GP61LPS sec-
ondary responding cells making IL-2 was less than primary
responding cells (Fig. 5B). To further confirm that LCMV
memory cells responded to reactivation in a similar fashion to
peptide and LPS memory cells, we examined the incorporation
of BrdU. As suggested by the reduced percentage of cells making
IL-2, fewer memory cells were in cycle between d5 and d8 than
primary responding cells (Fig. 5C).
Reactivation with a more inflammatory Ag may allow the
memory cells to proliferate to the same extent as primary
responding cells. To examine this, we did the converse experi-
ment and measured the extent of proliferation of memory cells
generated with GP61LPS to LCMV infection. Although mem-
ory cells expanded more in response to LCMV than GP61LPS,
this differences was apparent only in the first 5 days of the
response (Fig. 5D). The fold expansion of the memory cells was
only 200, compared with an estimated 4- to 6,000-fold expansion
in the primary response. Moreover, the memory cells incorpo-
Fig. 5. Memory cells generated by or reactivated with LCMV proliferate poorly. (A) B6 mice were primed with LCMV (open squares) or GP61LPS (closed
squares) i.p. 35 days later some of each type of mouse were immunized with GP61LPS i.p., or naı¨ve mice were primed with GP61LPS (closed triangles). The
numbers of IAb/GP61 tet T cells in the spleens of these mice were examined on d5. Also examined were the numbers of memory tet cells in LCMV (open
diamonds) or GP61LPS (closed diamonds) mice primed 40 days previously. Each point represents a mouse, and the line shows the mean of the group. The gray
line indicates the limit of detection for the tet staining. (B) As in A, but splenocytes were stimulated ex vivo with/without GP61 peptide in the presence of Golgi
plug and the number of IL-2 producing cells examined. The percentage of tet cells making IL-2 was then calculated for each mouse. (C) As in A, but mice were
given BrdU drinking water between d5 and d8 after immunization with GP61LPS and the percentage of tet cells BrdU calculated. Representative of two
experiments with four mice per group. (D) B6 mice primed with GP61LPS 8 weeks earlier were infected with LCMV (open squares) or immunized with GP61LPS
(closed squares) or naı¨ve mice were infected with LCMV (open triangles). The numbers of IAb/GP61 tet cells present in the spleens of the mice were examined.
The dotted line indicates the hypothesized expansion of primary responding GP61-specific cells from d0 to d5; the gray line indicates the level of background
staining. (E) As in D, but the mice were given BrdU drinking water from d7 to d9 and the percentage of IAb/GP61 tet/BrdU cells analyzed on d9.
Representative of two experiments with four mice per group.
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rated less BrdU than the cells in the primary response between
d5 and d7 regardless of the restimulation (Fig. 5E).
Discussion
Memory responses are considered to be better than primary
responses, thereby providing enhanced protection to the host.
We show this may be a matter of definition and call into question
the criteria used to define memory. Here, we show that CD4
memory T cells curtail their own proliferation as a result of
changes in cytokine production. Our results confirm and extend
other reports on this subject as in both a viral and a bacterial
model, Ag-specific CD4 cells were found to expand at a similar
or reduced rate to primary responding cells respectively upon
recall (6, 7). However, in both systems, memory CD8 T cells
could have affected the amount of Ag presentation by killing
infected cells more rapidly (24), an issue, we have avoided by
examining the response to a single CD4 epitope in the absence
of a CD8 T cell response. Moreover, we showed that the memory
cells proliferated to a reduced extent after transfer to naı¨ve hosts
in which the primary response proceeded as normal, demon-
strating that neither competition for resources nor space are the
causes of the reduced expansion. These data clearly show that
primary and secondary responding cells are intrinsically differ-
ent and explain the earlier peak of memory responses; this is
neither a result of changes in Ag presentation nor T cell
migration but a consequence of the reduced proliferation of the
memory cells several days into the response.
In contrast to this result, Mercia et al. (25) found that TCR Tg
memory cells proliferated more after transfer to naı¨ve hosts. Our
results may differ for several reasons: first, they transferred a
large number of TCR Tg cells rather than studying an endoge-
nous CD4 T cell response as we have done. This large population
may affect the differentiation of memory cells (12, 13). Second,
they used a persistent Ag that may have caused an anergized
phenotype in the memory cells that was alleviated after transfer.
To avoid this, we used soluble Ag and adjuvant. Our system was
also devised so that the majority, if not all, of the Ag-specific cells
would receive sufficient signals to be fully activated, avoiding the
differentiation of two classes of memory T cells with distinct
proliferative capacities (26). Indeed, we do not believe that the
low fold expansion of the memory cells can be explained by their
differentiation into TEM cells because, although they were
CD62Llo, the majority of the memory cells in our experiments
expressed CCR7 (Fig. S1).
The requirement for IL-2 at later stages of the response is
reminiscent of findings that IL-2 sustains the expansion of and
is more critical in the secondary response of CD8 T cells (27, 28).
Our findings suggest that the IL-2 must be consumed in an
autocrine fashion, because IL-2 from the primary host cells could
not support memory cell proliferation. However, the populations
may be present in separate locations of the spleen preventing the
IL-2 from the primary responding cells from reaching the
memory cells. The question arises of why fewer memory cells
make IL-2? Perhaps IFN from the memory cells causes local
APC tomake IL-12, which in turn reduces the percentage of cells
making IL-2 (29)?
Although the peptideLPS memory cells had a reduced fold
expansion, they did make more IFN than primary cells. The
percentage of IFN Ag-specific CD4 cells in both responses is
much less than that found in LCMV infection (7, 19). We
excluded the possibility that this low effector cell differentiation
explained the poor expansion by examining the response of
CD4 LCMV memory cells. In response to GP61LPS reac-
tivation, the LCMVmemory cells actually responded worse than
GP61LPS memory cells. In the converse experiment, we also
showed that even in the very inflammatory environment of a
LCMV infection, memory cells still expanded much less than
cells undergoing a primary response. This results contrasts with
a recent article that found that TCR Tg cells responding to
LCMV accumulated to greater numbers than primary respond-
ing TCR Tg cells in the same host (30). Our results may differ
for several reasons, in particular because of the differences
between endogenous T cells (studied here) and TCR Tg cells
used in the other study.
Despite the low percentage of memory cells making IFN, we
found that blocking IFN restored the percentage of these cells
that entered cell division to that of primary responding cells.
IFN increases the contraction of CD4 cells (31, 32) but can also
enhance CD4 T cell responses (33). By examining the responses
of IFNR sufficient and deficient TCR Tg cells, Whitton and
colleagues (33) have examined the effect of IFN from the
primary response onwards. We show that IFN inhibits the
proliferation of only the memory cells, suggesting that IFNmay
act in an opposing manner on primary and secondary responding
cells. However, we found no differences in the numbers WT and
IFNR KO cells at any stages of the response suggesting that, in
this system, IFN does not enhance the CD4 T cell responses.
We found that the IFN did not act directly on the memory
cells; a similar result has been recently demonstrated for CD8 T
cells (34). Why then were only the memory cells and not the
primary responding cells in the same host inhibited by IFN? As
suggested above, the populations may be present in different
areas of the spleen so the IFN would only act locally. Alter-
natively, the timings of T cell and APC interactions may differ
such that the effects of the IFN were limited by time. In support
of this, secondarily responding CD8 T cells exit the T cell area
of the spleen more rapidly than primary responding cells (35).
Effector cytokine producing CD4 memory T cells have been
shown to be protective in viral, bacterial and parasitic infections
(36–38), suggesting that memory CD4 cells may provide pro-
tection to the host via an enhanced effector cytokine response
that directs other immune cells. Thus, inhibition of proliferation
may be a direct and inevitable consequence of the effector
functions of the memory cells; somehow during effective im-
mune responses CD4 memory cells must strike the right balance
between expansion and effector function.
Materials and Methods
Mice and Immunizations. Female B6, B6.PL-Thy1a/CyJ (Thy1.1), B6.SJL-
PtprcaPep3b/BoyJ (CD45.1), and B6.129S7-Ifng KO mice were obtained from The
Jackson Laboratory; 508 TCR Tg mice expressing a TCR specific for IAb/3K (39) and
IFN receptor knockout mice were bred at the National Jewish Medical and
Research Center (NJC). All mice were maintained in a specific-pathogen-free
environment in accordance with institutional guidelines in the Animal Care
Facility at the NJC. Mice were age matched within experiments and primed at
6–10 weeks of age. Mice were immunized with 10g of 3K (FEAQKAKANKAVD)
or GP61 (GLNGPDIYKGVYQFKSVEFD) supplied by the Molecular Resources Cen-
ter at NJC and 7 g of LPS (Escherichia coli, Difco) i.v. or i.p. in GP61LPS
immunized mice. Mice were infected with a single dose of 2  105 plaque-
forming units of LCMV (Armstrong) i.p. In experiments in which memory cells
were transferred, donor mice were primed as above and 4–6 weeks later were
immunized again. Cells were harvested 4–15 weeks later.
Cell Transfer. Spleens and LN (brachial, axillary, inguinal, popliteal, lumbar)
were taken from memory B6 or B6.PL mice or from 508 TCR Tg mice. A single
cell suspension was prepared and red blood cells lysed. Cells were washed and
injected i.v.
Cell Analysis. Cells were obtained from red blood cell lysed spleens. For liver,
mice were perfused, suspensions prepared by using a cell strainer, large debris
removed by centrifugation and lymphocytes separated by resuspending cells
in 46% Percoll and underlaying with 54% Percoll.
Flow Cytometry. PE-labeled IAb/3K tetramer was produced as described (18).
PE-labeled IAb/GP66–77 tetramer (referred to as IAb/GP61) was supplied by the
National Institute of Health (NIH) tetramer core facility. Single-cell suspen-
sions were stained with tetramer at 37°C for 2 h. Antibodies to surface markers
(SI Text) were added and the cells incubated for a further 20 min at 4°C. Tet
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cells were defined by gating on live CD4 cells that were B220, F4/80, MHC class
II negative (dump) negative and CD44hi.
For analysis of naı¨ve IAb/3K or Gp61-specific cells, spleens, and LN (as above
and cervical and mesenteric) were taken from naı¨ve mice or mice primed 7–9
days earlier with 3K or Gp61LPS i.v. Total cells were stained with tetramer
and antibodies against CD44, CD62L, CD127, CD4, CD8, B220, F4/80, MHC II,
and TCRc. Total cells were acquired in four to seven samples of 10 million
events. Naı¨ve IAb/3K cells were gated through forward and side scatter, CD4,
dump (CD8, B220, F4/80, MHC II), CD127, TCR, CD44lo, and CD62Lhi. The
number of tet cells for each acquired sample of 10 million events was
calculated and a mean for each mouse calculated.
For analysis of cell cycle entry, mice were either given 1 mg of BrdU (Sigma)
i.p. 15 h before death or drinking water containing 0.8 mg/ml of BrdU for 2–3
days before death. BrdU drinking water was replaced daily and always
protected from light. Staining was carried out as described (40) after tetramer
and surface antibody staining.
For analysis of intracellular cytokine production, splenocytes were incu-
bated ex vivo with 5 g/ml 3K or GP61 peptide and 1 l/ml Golgi plug (BD) for
6 h. Cells were stained with surface antibodies and then fixed and permeabil-
ized by using the BD Cytofix/Cytoperm kit according to manufacturer’s in-
structions before staining with anticytokine antibodies. Cells were gated on
live CD44hi CD4 cells that were B220, F4/80 and MHC class II negative. Ag-
specific cytokine was defined as staining above that from cells cultured in the
absence of peptide and this number used to calculate the percentage of tet
cells making cytokine in each mouse.
To examine primary or memory responses 2–5 million events were collected
on a CyAn LX or CyAn ADP (Dakocytomation) and data analyzed by using
FlowJo version 8 (TreeStar).
In Vivo Treatment with IL-2 or Anti-IFN. Memory cell recipients were given 1.5
g of IL-2 (R&D) i.p. on d3–6 or PBS or a total of 1 mg of anti-IFN (grown in
FCS depleted of IgG) or rat IgG (Jackson Immunoresearch) i.p. on d3–4 of the
response.
Bone Marrow Chimeras. CD45.1 B6 mice were irradiated with 900Rads and
reconstituted with 5106 cells of 50:50 CD45.1 WT and CD45.2 IFNR KO bone
marrow. Chimeras were primed 8 weeks after reconstitution.
Statistics. Statistical significance determined by using Student’s two-tailed t
test (GraphPad Prism V4).
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